The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Accuray, Inc. | Common | 004397105 | 4,201 | 731,943 | SH | SOLE | 731,943 | 0 | 0 | ||
Acorda Therapeutics, Inc. | Common | 00484M106 | 3,724 | 112,881 | SH | SOLE | 112,881 | 0 | 0 | ||
Actavis, Inc. | Common | 00507K103 | 11,549 | 91,500 | SH | SOLE | 91,500 | 0 | 0 | ||
Aetna, Inc. | Common | 00817Y108 | 12,533 | 197,241 | SH | SOLE | 197,241 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 12,651 | 935,758 | SH | SOLE | 935,758 | 0 | 0 | ||
Alere, Inc. | Common | 01449J105 | 7,756 | 316,553 | SH | SOLE | 316,553 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 34,251 | 371,329 | SH | SOLE | 371,329 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 5,589 | 194,870 | SH | SOLE | 194,870 | 0 | 0 | ||
Allergan, Inc. | Common | 018490102 | 7,841 | 93,077 | SH | SOLE | 93,077 | 0 | 0 | ||
Amarin Corporation plc | Sponsored ADR | 023111206 | 7,901 | 1,362,298 | SH | SOLE | 1,362,298 | 0 | 0 | ||
Amgen, Inc. | Common | 031162100 | 19,746 | 200,143 | SH | SOLE | 200,143 | 0 | 0 | ||
ARIAD Pharmaceuticals, Inc. | Common | 04033A100 | 7,223 | 412,965 | SH | SOLE | 412,965 | 0 | 0 | ||
Auxilium Pharmaceuticals, Inc. | Common | 05334D107 | 2,121 | 127,520 | SH | SOLE | 127,520 | 0 | 0 | ||
Baxter International, Inc. | Common | 071813109 | 5,381 | 77,675 | SH | SOLE | 77,675 | 0 | 0 | ||
Biogen Idec, Inc. | Common | 09062X103 | 41,315 | 191,983 | SH | SOLE | 191,983 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 4,184 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 59,629 | 510,046 | SH | SOLE | 510,046 | 0 | 0 | ||
Ceres, Inc. | Common | 156773103 | 1,304 | 416,481 | SH | SOLE | 416,481 | 0 | 0 | ||
Cornerstone Therapeutics, Inc. | Common | 21924P103 | 529 | 66,112 | SH | SOLE | 66,112 | 0 | 0 | ||
Cubist Pharmaceuticals, Inc. | Common | 229678107 | 12,846 | 265,972 | SH | SOLE | 265,972 | 0 | 0 | ||
CVS Caremark Corporation | Common | 126650100 | 4,094 | 71,591 | SH | SOLE | 71,591 | 0 | 0 | ||
Dendreon Corporation | Common | 24823Q107 | 1,552 | 376,728 | SH | SOLE | 376,728 | 0 | 0 | ||
Elan Corporation plc | ADR | 284131208 | 3,429 | 242,500 | SH | SOLE | 242,500 | 0 | 0 | ||
Endo Pharmaceutical Holdings, Inc. | Common | 29264F205 | 4,643 | 126,215 | SH | SOLE | 126,215 | 0 | 0 | ||
Endocyte, Inc. | Common | 29269A102 | 790 | 60,200 | SH | SOLE | 60,200 | 0 | 0 | ||
Forest Laboratories, Inc. | Common | 345838106 | 6,007 | 146,500 | SH | SOLE | 146,500 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 77,056 | 1,504,712 | SH | SOLE | 1,504,712 | 0 | 0 | ||
Hologic, Inc. | Common | 436440101 | 11,443 | 592,915 | SH | SOLE | 592,915 | 0 | 0 | ||
iCAD, Inc. | Common | 44934S206 | 531 | 88,527 | SH | SOLE | 88,527 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 5,051 | 56,265 | SH | SOLE | 56,265 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 7,771 | 103,841 | SH | SOLE | 103,841 | 0 | 0 | ||
Immunogen, Inc. | Common | 45253H101 | 6,533 | 393,773 | SH | SOLE | 393,773 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 6,876 | 344,683 | SH | SOLE | 344,683 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 9,269 | 421,300 | SH | SOLE | 421,300 | 0 | 0 | ||
IntelliPharmaCeutics International, Inc. | Common | 458173101 | 2,811 | 1,735,000 | SH | SOLE | 1,735,000 | 0 | 0 | ||
Ironwood Pharmaceuticals, Inc. | Common | 46333X108 | 7,642 | 768,050 | SH | SOLE | 768,050 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 6,511 | 56,862 | SH | SOLE | 56,862 | 0 | 0 | ||
Medivation, Inc. | Common | 58501N101 | 10,157 | 206,439 | SH | SOLE | 206,439 | 0 | 0 | ||
MEI Pharma Inc. | Common | 55279B202 | 1,061 | 148,820 | SH | SOLE | 148,820 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 13,778 | 296,620 | SH | SOLE | 296,620 | 0 | 0 | ||
Merrimack Pharmaceuticals Inc. | Common | 590328100 | 3,618 | 537,600 | SH | SOLE | 537,600 | 0 | 0 | ||
Mylan, Inc. | Common | 628530107 | 15,149 | 488,209 | SH | SOLE | 488,209 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 9,473 | 707,990 | SH | SOLE | 707,990 | 0 | 0 | ||
OncoGenex Pharmaceuticals, Inc. | Common | 68230A106 | 1,108 | 113,100 | SH | SOLE | 113,100 | 0 | 0 | ||
Onyx Pharmaceuticals, Inc. | Common | 683399109 | 22,040 | 253,856 | SH | SOLE | 253,856 | 0 | 0 | ||
Perrigo Company | Common | 714290103 | 24,515 | 202,607 | SH | SOLE | 202,607 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 31,583 | 711,800 | SH | SOLE | 711,800 | 0 | 0 | ||
Questcor Pharmaceuticals, Inc. | Common | 74835Y101 | 7,907 | 173,928 | SH | SOLE | 173,928 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 62,912 | 279,759 | SH | SOLE | 279,759 | 0 | 0 | ||
Rigel Pharmaceuticals, Inc. | Common | 766559603 | 2,763 | 827,100 | SH | SOLE | 827,100 | 0 | 0 | ||
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 5,665 | 270,031 | SH | SOLE | 270,031 | 0 | 0 | ||
Sanofi | Right 12/31/2020 | 80105N113 | 200 | 103,665 | SH | SOLE | 103,665 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 14,661 | 154,153 | SH | SOLE | 154,153 | 0 | 0 | ||
Supernus Pharmaceuticals Inc. | Common | 868459108 | 905 | 140,800 | SH | SOLE | 140,800 | 0 | 0 | ||
Synta Pharmaceuticals Corporation | Common | 87162T206 | 1,880 | 376,750 | SH | SOLE | 376,750 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 12,210 | 311,476 | SH | SOLE | 311,476 | 0 | 0 | ||
UnitedHealth Group, Inc. | Common | 91324P102 | 5,398 | 82,436 | SH | SOLE | 82,436 | 0 | 0 | ||
Verastem, Inc. | Common | 92337C104 | 12,283 | 884,920 | SH | SOLE | 884,920 | 0 | 0 | ||
Vertex Pharmaceuticals, Inc. | Common | 92532F100 | 36,274 | 454,164 | SH | SOLE | 454,164 | 0 | 0 | ||
Warner Chilcott plc | Shares A | G94368100 | 15,562 | 782,797 | SH | SOLE | 782,797 | 0 | 0 |